Cote d'Ivoire vs Portugal: The number of people with susceptibility test result for rifampicin
Cote d'Ivoire
59.19
in 2021
Portugal
54.52
in 2021
Cote d'Ivoire rank
111th
Portugal rank
112th
The number of people with susceptibility test result for rifampicin over time
- Cote d'Ivoire
- Portugal
How they compare
Cote d'Ivoire currently reports 59.19 against 54.52 in Portugal, a difference of 4.67.
That makes Cote d'Ivoire's figure about 1.1 times Portugal's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Portugal ahead.
Cote d'Ivoire ranks 111th and Portugal ranks 112th of 146 countries.
Portugal has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cote d'Ivoire | Portugal | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 23.43 | 58.49 | 35.06 | Portugal |
| 2020s | 34.58 | 53.61 | 19.03 | Portugal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Cote d'Ivoire or Portugal?
- Cote d'Ivoire, at 59.19 against 54.52 in Portugal as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Cote d'Ivoire and Portugal?
- 4.67, with Cote d'Ivoire ahead.
- How many years of comparable data are there for Cote d'Ivoire and Portugal?
- 5 years are reported by both, from 2017 to 2021.
- How do Cote d'Ivoire and Portugal rank globally for the number of people with susceptibility test result for rifampicin?
- Cote d'Ivoire ranks 111th and Portugal ranks 112th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.